As previously reported, Wells Fargo analyst Stephen Baxter upgraded Cardinal Health (CAH) to Overweight from Equal Weight with a price target of $179, up from $136. The firm sees the improved valuation as justified by strong industry backdrop, improving mix, and execution. Wells’ estimates are above consensus and have upward bias if Pharma outperformance continues or GMPD tariff pressure is not worst-case.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health upgraded to Overweight from Equal Weight at Wells Fargo
- Sector Spotlight: Trump executive order targets drug prices
- Trump’s drug-price crackdown may lead to minor concessions, WSJ reports
- White House publishes Trump executive order aimed at lowering drug prices
- Trump says will ‘cut out middlemen’ to reduce drug prices